| Peter Maguire, MD | |
|
795 El Camino Real, Palo Alto, CA 94301-2302 | |
| (650) 853-2981 | |
| Not Available |
| Full Name | Peter Maguire |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 33 Years |
| Location | 795 El Camino Real, Palo Alto, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457360851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | G77607 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" - monitoring cancer progression without undergoing treatment - have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.
Shimadzu Corporation today introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of innovation.
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.
› Verified 5 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" - monitoring cancer progression without undergoing treatment - have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.
Shimadzu Corporation today introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of innovation.
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Maguire, MD 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (650) 853-4982 | Peter Maguire, MD 795 El Camino Real, Palo Alto, CA 94301-2302 Ph: (650) 853-2981 |
News Archive
An intervention that consisted of home blood pressure (BP) telemonitoring with pharmacist management resulted in improvements in BP control and decreases in BP during 12 months, compared with usual care, and improvement in BP that was maintained for 6 months following the intervention, according to a study in the July 3 issue of JAMA.
Men who refuse surgery for prostate cancer and instead opt for "watchful waiting" - monitoring cancer progression without undergoing treatment - have a significantly worse long-term survival rate than those patients that choose radiotherapy, according to researchers at Henry Ford Hospital in Detroit.
Shimadzu Corporation today introduced the GCMS-TQ8030 ultra fast triple quadrupole gas chromatograph mass spectrometer, achieving the next step forward in Shimadzu's GC-MS history of innovation.
Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.
› Verified 5 days ago
Muhammad Hassan Bashir, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Richard Barry Moss, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-498-5710 | |
Sean Austin Mcghee, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Steven Barry Machtinger, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Sara Kleinman, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Robert Bocian, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Dr. Hailen Mak, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1101 Welch Rd, Suite A-2, Palo Alto, CA 94304 Phone: 650-322-3847 Fax: 650-322-3249 |